Preimplantation genetic diagnosis in marfan syndrome
- PMID: 23781359
- PMCID: PMC3678443
- DOI: 10.1155/2013/542961
Preimplantation genetic diagnosis in marfan syndrome
Abstract
Marfan syndrome (MFS) is a systemic hereditable disorder of the connective tissue with mainly cardiovascular manifestations, such as aortic dilatation and dissection. We describe a case of a 32-year-old Caucasian woman, clinically asymptomatic with MFS who presented for genetic consultation to prevent the transmission of disease to her offspring. She underwent controlled ovarian stimulation (COH), in vitro fertilization (IVF) combined with preimplantation genetic diagnosis (PGD), and a singleton pregnancy with positive fetal heart rate was revealed. At 34 weeks' gestation she delivered vaginally a healthy premature male infant weighting 2440 gr. The patient remained asymptomatic during pregnancy, delivery, and 3 months postpartum. It is has to be mentioned that the availability of PGD is essential to prevent the transmission of disease to the next generation.
References
-
- Ho NC, Tran JR, Bektas A. Marfan’s syndrome. The Lancet. 2005;366(9501):1978–1981. - PubMed
-
- De Paepe A, Devereux RB, Dietz HC, Hennekam RC, Pyeritz RE. Revised diagnostic criteria for the Marfan syndrome. American Journal of Medical Genetics. 1996;62(4):417–426. - PubMed
-
- Dietz HC, Pyeritz RE. Mutations in the human gene for fibrillin-1 (FBN1) in the Marfan syndrome and related disorders. Human Molecular Genetics. 1995;4:1799–1809. - PubMed
-
- Goland S, Barakat M, Khatri N, Elkayam U. Pregnancy in marfan syndrome maternal and fetal risk and recommendations for patient assessment and management. Cardiology in Review. 2009;17(6):253–262. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
